CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.52
2.7%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Rigel Pharmaceuticals Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 1.48
Open* 1.54
1-Year Change* 3.36%
Day's Range* 1.5 - 1.6
52 wk Range 0.71-2.04
Average Volume (10 days) 894.89K
Average Volume (3 months) 25.08M
Market Cap 233.66M
P/E Ratio -100.00K
Shares Outstanding 174.37M
Revenue 132.37M
EPS -0.14
Dividend (Yield %) N/A
Beta 0.91
Next Earnings Date Mar 5, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 1, 2024 1.52 0.02 1.33% 1.50 1.61 1.46
Feb 29, 2024 1.48 -0.06 -3.90% 1.54 1.55 1.44
Feb 28, 2024 1.52 0.04 2.70% 1.48 1.54 1.46
Feb 27, 2024 1.47 0.05 3.52% 1.42 1.54 1.42
Feb 26, 2024 1.38 0.08 6.15% 1.30 1.47 1.30
Feb 23, 2024 1.29 0.00 0.00% 1.29 1.30 1.22
Feb 22, 2024 1.27 0.13 11.40% 1.14 1.31 1.12
Feb 21, 2024 1.10 -0.01 -0.90% 1.11 1.11 1.09
Feb 20, 2024 1.11 -0.03 -2.63% 1.14 1.16 1.10
Feb 16, 2024 1.15 -0.02 -1.71% 1.17 1.20 1.14
Feb 15, 2024 1.19 0.04 3.48% 1.15 1.20 1.14
Feb 14, 2024 1.15 0.05 4.55% 1.10 1.16 1.10
Feb 13, 2024 1.10 -0.06 -5.17% 1.16 1.16 1.09
Feb 12, 2024 1.19 0.00 0.00% 1.19 1.25 1.18
Feb 9, 2024 1.18 0.08 7.27% 1.10 1.21 1.10
Feb 8, 2024 1.11 0.03 2.78% 1.08 1.12 1.06
Feb 7, 2024 1.10 -0.08 -6.78% 1.18 1.18 1.09
Feb 6, 2024 1.20 0.05 4.35% 1.15 1.21 1.14
Feb 5, 2024 1.15 0.04 3.60% 1.11 1.20 1.10
Feb 2, 2024 1.12 0.01 0.90% 1.11 1.14 1.09

Rigel Events

Time (UTC) Country Event
Tuesday, March 5, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 Rigel Pharmaceuticals Inc Earnings Release
Q4 2023 Rigel Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-

Time (UTC)

21:30

Country

US

Event

Q4 2023 Rigel Pharmaceuticals Inc Earnings Call
Q4 2023 Rigel Pharmaceuticals Inc Earnings Call

Forecast

-

Previous

-
Tuesday, April 30, 2024

Time (UTC)

20:00

Country

US

Event

Q1 2024 Rigel Pharmaceuticals Inc Earnings Release
Q1 2024 Rigel Pharmaceuticals Inc Earnings Release

Forecast

-

Previous

-
Friday, May 24, 2024

Time (UTC)

14:30

Country

US

Event

Rigel Pharmaceuticals Inc Annual Shareholders Meeting
Rigel Pharmaceuticals Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 120.242 149.236 108.621 59.288 44.509
Revenue 120.242 149.236 108.621 59.288 44.509
Total Operating Expense 175.792 161.732 137.594 128.379 117.192
Selling/General/Admin. Expenses, Total 112.451 91.891 76.598 74.588 70.002
Research & Development 60.272 65.237 60.101 52.885 46.903
Unusual Expense (Income) 1.32 3.521 0
Operating Income -55.55 -12.496 -28.973 -69.091 -72.683
Interest Income (Expense), Net Non-Operating -3.023 -4.813 -0.771 2.197 2.203
Gain (Loss) on Sale of Assets 0 0
Net Income Before Taxes -58.573 -17.309 -29.744 -66.894 -70.48
Net Income After Taxes -58.573 -17.914 -29.744 -66.894 -70.48
Net Income Before Extra. Items -58.573 -17.914 -29.744 -66.894 -70.48
Net Income -58.573 -17.914 -29.744 -66.894 -70.48
Income Available to Common Excl. Extra. Items -58.573 -17.914 -29.744 -66.894 -70.48
Income Available to Common Incl. Extra. Items -58.573 -17.914 -29.744 -66.894 -70.48
Diluted Net Income -58.573 -17.914 -29.744 -66.894 -70.48
Diluted Weighted Average Shares 172.406 170.492 168.754 167.4 160.529
Diluted EPS Excluding Extraordinary Items -0.33974 -0.10507 -0.17626 -0.39961 -0.43905
Diluted Normalized EPS -0.33208 -0.09165 -0.17626 -0.39961 -0.43905
Total Extraordinary Items
Cost of Revenue, Total 1.749 1.083 0.895 0.906 0.287
Gross Profit 118.493 148.153 107.726 58.382 44.222
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 26.886 26.07 51.278 22.41 29.819
Revenue 26.886 26.07 51.278 22.41 29.819
Cost of Revenue, Total 1.075 0.977 0.342 0.25 1.036
Gross Profit 25.811 25.093 50.936 22.16 28.783
Total Operating Expense 32.153 38.795 49.199 40.813 42.784
Selling/General/Admin. Expenses, Total 26.306 27.729 32.172 25.897 26.981
Research & Development 4.772 10.089 15.365 14.666 14.767
Operating Income -5.267 -12.725 2.079 -18.403 -12.965
Interest Income (Expense), Net Non-Operating -1.333 -0.811 -0.678 -0.634 -0.527
Net Income Before Taxes -6.6 -13.536 1.401 -19.037 -13.492
Net Income After Taxes -6.6 -13.536 1.401 -19.037 -13.492
Net Income Before Extra. Items -6.6 -13.536 1.401 -19.037 -13.492
Net Income -6.6 -13.536 1.401 -19.037 -13.492
Income Available to Common Excl. Extra. Items -6.6 -13.536 1.401 -19.037 -13.492
Income Available to Common Incl. Extra. Items -6.6 -13.536 1.401 -19.037 -13.492
Diluted Net Income -6.6 -13.536 1.401 -19.037 -13.492
Diluted Weighted Average Shares 173.748 173.568 140.1 172.836 172.147
Diluted EPS Excluding Extraordinary Items -0.03799 -0.07799 0.01 -0.11014 -0.07837
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.03799 -0.07799 0.01942 -0.11014 -0.07837
Unusual Expense (Income) 1.32
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 115.903 154.467 88.983 119.005 136.987
Cash and Short Term Investments 58.206 124.967 57.327 98.078 128.537
Cash & Equivalents 24.459 18.89 30.373 22.521 76.322
Short Term Investments 33.747 106.077 26.954 75.557 52.215
Total Receivables, Net 40.32 15.472 15.973 10.111 4.077
Accounts Receivable - Trade, Net 40.32 15.472 15.973 10.111 4.077
Prepaid Expenses 8.259 7.412 14.045 9.462 3.479
Total Assets 134.279 167.328 110.378 147.569 139.109
Property/Plant/Equipment, Total - Net 2.787 11.887 20.571 27.868 1.387
Property/Plant/Equipment, Total - Gross 13.594 26.438 34.247 40.913 14.241
Accumulated Depreciation, Total -10.807 -14.551 -13.676 -13.045 -12.854
Other Long Term Assets, Total 0.64 0.974 0.824 0.696 0.735
Total Current Liabilities 65.211 63.554 40.841 58.212 27.734
Accounts Payable 22.508 3.795 3.707 4.152 6.391
Accrued Expenses 24.192 43.657 34.116 28.772 20.313
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 18.511 16.102 3.018 25.288 1.03
Total Liabilities 147.895 136.954 76.352 93.754 29.232
Total Long Term Debt 39.448 19.914 19.815 9.81 0
Other Liabilities, Total 43.236 53.486 15.696 25.732 1.498
Total Equity -13.616 30.374 34.026 53.815 109.877
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.174 0.172 0.169 0.168 0.167
Additional Paid-In Capital 1368.82 1354.19 1339.83 1329.85 1319.07
Retained Earnings (Accumulated Deficit) -1382.46 -1323.89 -1305.97 -1276.23 -1209.33
Other Equity, Total -0.153 -0.102 -0.004 0.023 -0.024
Total Liabilities & Shareholders’ Equity 134.279 167.328 110.378 147.569 139.109
Total Common Shares Outstanding 173.399 171.602 169.317 167.988 167.172
Total Inventory 9.118 6.616 1.638 1.354 0.894
Long Term Debt 39.448 19.914 19.815 9.81
Intangibles, Net 14.949
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 95.024 100.925 106.972 115.903 110.44
Cash and Short Term Investments 62.351 64.357 58.662 58.206 81.642
Cash & Equivalents 45.414 48.812 40.285 24.459 29.866
Short Term Investments 16.937 15.545 18.377 33.747 51.776
Total Receivables, Net 23.546 20.819 29.366 40.32 15.525
Accounts Receivable - Trade, Net 23.546 20.819 29.366 40.32 15.525
Total Inventory 6.112 10.782 11.077 9.118 7.116
Prepaid Expenses 3.015 4.967 7.867 8.259 6.157
Total Assets 115.324 117.091 123.612 134.279 115.609
Property/Plant/Equipment, Total - Net 1.198 1.212 1.417 2.787 4.685
Other Long Term Assets, Total 4.956 0.541 0.542 0.64 0.484
Total Current Liabilities 48.273 44.023 45.518 65.211 47.265
Accounts Payable 7.999 5.24 6.295 22.508 2.721
Accrued Expenses 19.55 18.044 18.146 24.192 37.263
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 20.724 20.739 21.077 18.511 7.281
Total Liabilities 147.158 145.206 147.869 147.895 135.443
Total Long Term Debt 59.659 59.574 59.484 39.448 39.468
Long Term Debt 59.659 59.574 59.484 39.448 39.468
Other Liabilities, Total 39.226 41.609 42.867 43.236 48.71
Total Equity -31.834 -28.115 -24.257 -13.616 -19.834
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.175 0.175 0.174 0.174 0.173
Additional Paid-In Capital 1376.29 1374.33 1371.59 1368.82 1364.14
Retained Earnings (Accumulated Deficit) -1408.29 -1402.59 -1395.99 -1382.46 -1383.86
Other Equity, Total -0.015 -0.025 -0.027 -0.153 -0.286
Total Liabilities & Shareholders’ Equity 115.324 117.091 123.612 134.279 115.609
Total Common Shares Outstanding 174.367 174.358 173.666 173.399 172.836
Intangibles, Net 14.146 14.413 14.681 14.949
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -58.573 -17.914 -29.744 -66.894 -70.48
Cash From Operating Activities -73.758 5.878 -52.185 -41.51 -58.826
Cash From Operating Activities 0.998 1.162 0.706 0.683 0.594
Non-Cash Items 12.866 12.912 7.175 8.042 6.938
Changes in Working Capital -29.049 9.718 -30.322 16.659 4.122
Cash From Investing Activities 72.777 -80.036 47.466 -23.656 24.964
Capital Expenditures -0.45 -0.627 -1.262 -1.455 -1.106
Other Investing Cash Flow Items, Total 73.227 -79.409 48.728 -22.201 26.07
Cash From Financing Activities 6.55 62.675 12.571 11.365 71.894
Issuance (Retirement) of Stock, Net 2.124 4.775 2.596 1.576 71.894
Net Change in Cash 5.569 -11.483 7.852 -53.801 38.032
Cash Interest Paid 2.495 1.5 1.18 0.137
Issuance (Retirement) of Debt, Net 19.542 0 9.975 9.789
Financing Cash Flow Items -15.116 57.9
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -13.536 -58.573 -59.974 -40.937 -27.445
Cash From Operating Activities -4.074 -73.758 -51.849 -38.548 -25.637
Cash From Operating Activities 0.357 0.998 0.714 0.474 0.237
Non-Cash Items 3.037 12.866 8.638 6.134 3.917
Cash Interest Paid 1.011 2.495 1.549 0.951 0.393
Changes in Working Capital 6.068 -29.049 -1.227 -4.219 -2.346
Cash From Investing Activities 0.777 72.777 54.179 43.724 22.629
Capital Expenditures -15 -0.45 -0.377 -0.188 -0.224
Other Investing Cash Flow Items, Total 15.777 73.227 54.556 43.912 22.853
Cash From Financing Activities 19.123 6.55 8.646 3.135 8.797
Issuance (Retirement) of Stock, Net 0.001 2.124 1.539 1.539 0.94
Net Change in Cash 15.826 5.569 10.976 8.311 5.789
Financing Cash Flow Items -0.828 -15.116 -12.435 -8.346 -2.118
Issuance (Retirement) of Debt, Net 19.95 19.542 19.542 9.942 9.975
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Armistice Capital LLC Hedge Fund 9.8071 17100000 76000 2023-06-30 MED
Soleus Capital Management, L.P. Hedge Fund 8.1313 14178015 1375000 2023-06-30 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.987 12182885 534082 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 6.2724 10936829 -422304 2023-06-30 LOW
Acadian Asset Management LLC Investment Advisor/Hedge Fund 2.6276 4581512 857949 2023-06-30 MED
Millennium Management LLC Hedge Fund 2.5784 4495757 -741360 2023-06-30 HIGH
Two Sigma Investments, LP Hedge Fund 2.2664 3951765 -678786 2023-06-30 HIGH
Morgan Stanley & Co. LLC Research Firm 2.1905 3819466 3371070 2023-06-30 MED
Jacobs Levy Equity Management, Inc. Investment Advisor/Hedge Fund 2.1271 3708876 -200616 2023-06-30 MED
Assenagon Asset Management S.A. Investment Advisor 2.0787 3624538 2317250 2023-06-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.0212 3524215 78060 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.954 3407050 132459 2023-06-30 LOW
Nuveen LLC Pension Fund 1.4093 2457278 -292841 2023-06-30 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.9904 1726922 -28172 2023-06-30 LOW
Rodriguez (Raul R) Individual Investor 0.9639 1680713 -20340 2023-02-06
Macquarie Investment Management Investment Advisor 0.9176 1600000 0 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 0.9068 1581126 -397592 2023-06-30 HIGH
CM Management, LLC Investment Advisor 0.8603 1500000 0 2023-06-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7794 1359010 15928 2023-06-30 LOW
Tamarack Advisers, LP Hedge Fund 0.7169 1250000 -750000 2023-06-30 HIGH

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Rigel Company profile

Rigel
Industry: Bio Therapeutic Drugs

611 Gateway Boulevard, Suite 900
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US

Income Statement

  • Annual
  • Quarterly

News

Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

18:44, 1 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

People also watch

Gold

2,083.15 Price
+1.890% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0108%
Overnight fee time 22:00 (UTC)
Spread 0.50

XRP/USD

0.65 Price
+6.150% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

62,095.30 Price
-0.900% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

18,286.90 Price
+1.410% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading